Prediction: Synopsys Could Become the Next $150 Billion Software Giant

Photo of Vandita Jadeja
By Vandita Jadeja Published

Quick Read

  • SNPS earns a BUY with a $471 price target implying 26% upside, even as shares have fallen 41% over the past 12 months.

  • Synopsys guides to $9.7B in revenue at a $72B market cap, a steep valuation discount to Cadence's $93B cap on far less revenue.

  • The five-year bull case projects $1,275 per share and a $200B market cap, contingent on Ansys synergies and agentic EDA adoption scaling.

  • The Motley Fool told its subscribers to buy Amazon in 2002, Netflix in 2004, and Nvidia in 2005. Stock Advisor still publishes two new stock picks every month — and over 23 years, has more than quadrupled the S&P 500. Click here to receive the next recommendation.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Prediction: Synopsys Could Become the Next $150 Billion Software Giant

© gorodenkoff / iStock via Getty Images

Shares of Synopsys (NASDAQ:SNPS | SNPS Price Prediction) have declined in 2026, prompting a fresh look at valuation. Our 24/7 Wall St. price target for Synopsys is $471.37, implying 26.14% upside from the current price of $373.69.

The recommendation is buy at a confidence level of 90%. Extended to a five-year horizon, our base case points to a share price that would push Synopsys past a $140 billion market cap and within striking distance of the $150 billion tier.

An infographic titled 'Synopsys (SNPS) • 12-Month Price Prediction' with a dark gray background and green and red accents. It displays the current price of $373.69, a target price of $471.37, and an upside of +26.14%, recommending 'BUY' with '90% CONFIDENCE'. The methodology section shows a weighted base price of $409.53, derived from trailing P/E, forward P/E, and analyst targets. A waterfall chart illustrates proprietary adjustments from the base price to the final target, detailing positive factors like Sector Momentum and Social Sentiment, and negative factors like Earnings Growth and Market Cap Dampening. Bull case scenarios include 'Ansys Integration Synergies' and 'Agentic EDA Adoption' with a 5-Year target of $1,275.10. Bear case scenarios list 'Operating Income Decline' and 'Export Controls & Geopolitical Risk' with a 12-Month target of $428.78. The bottom line reiterates 'BUY | TARGET: $471.37 (+26.14%)' with a thesis on AI-driven semiconductor demand and Ansys synergies.
24/7 Wall St.
Metric Value
Current Price $373.69
24/7 Wall St. Price Target $471.37
Upside 26.14%
Recommendation BUY
Confidence Level 90%

Why Synopsys Sold Off Into a Buying Zone

Synopsys has fallen 20.44% year to date and 41.23% over the past 12 months, trading 13% below the 52-week high of $646.28 and near the 52-week low of $366.

The operating story keeps improving. Q2 FY2026 revenue of $2.276 billion rose 42% and non-GAAP EPS of $3.35 beat the $3.16 consensus. Management raised full-year non-GAAP EPS guidance to a midpoint of $14.76 and free cash flow to $2 billion.

CEO Sassine Ghazi said “AI is scaling semiconductor demand, architectural diversity, and complexity of both chips and the systems they power, driving increased demand across our portfolio.”

SNPS price target

The Case for $600 and a $150B Market Cap

The bull thesis rests on three pillars. First, Ansys integration is unlocking joint offerings neither company could sell alone. Multiphysics fusion is delivering “up to 3x faster design closure” in trials, with a $400 million semiconductor multiphysics synergy target starting in FY2027.

Second, agentic EDA is a live monetization inflection: 20 customers are evaluating solutions across more than 25 specialized AI agents, and management is layering consumption pricing on top of seats.

Third, IP is recovering, with PCIe 7.0 winning greater than 90% of deals and 18 new licenses booked in Q2.

Our 12-month bull case sits at $638.01, and the five-year bull case reaches $1,275.10, which would push Synopsys well past $200 billion in market cap.

What Could Go Wrong

GAAP operating income fell 68% in Q2 under $403.6 million of quarterly Ansys intangibles amortization, and long-term debt sits near $10 billion.

Morgan Stanley flagged growth deceleration, and prediction-market signals point to a modestly lower $341.94 target. Bulls counter that amortization is non-cash, non-GAAP EPS is tracking roughly 14.4% growth, and management has paid down $3.46 billion of debt in the first half of FY2026. Our bear case shakeout takes shares to $428.78 over 12 months.

SNPS analyst ratings

How Synopsys Compares to Cadence and Autodesk

The most direct comparable is Cadence Design Systems (NASDAQ:CDNS), the other pillar of the EDA duopoly. Cadence carries a market cap of $93.39 billion, roughly 62% of the $150 billion tier we are handicapping for Synopsys.

Cadence guided FY2026 revenue to a midpoint near $6.3 billion with non-GAAP operating margins of 43.75% to 44.75%. Synopsys guides to a higher $9.665 billion in revenue at a lower market cap, making our 24/7 Wall St. price target look conservative.

Autodesk (NASDAQ:ADSK), an AI-focused design-software peer, sits at a a comparable design-software peer with a smaller market cap and slower recent revenue growth than Synopsys. Synopsys is growing revenue faster, and the peer framing argues it should command a premium multiple given AI-native EDA exposure.

Company Market Cap Recent Revenue Growth
Synopsys $71.55B 42.0% Q2
Cadence $93.39B 24.2% Q2
Autodesk $51.78B 18.4% Q1

Synopsys Price Prediction 2026 to 2030

Our 24/7 Wall St. price target of $471.37, a buy rating, and 90% confidence hinge on one call: AI continues to accelerate chip design starts, and Synopsys operates the toll road.

The bullish view rests on the Ansys deal compounding into a durable silicon-to-systems platform. The cautious view centers on whether the $10 billion debt load or China export controls will constrain earnings power through 2027.

Year 24/7 Wall St. Price Target
2026 $471.37
2027 $567.24
2028 $631.05
2029 $688.10
2030 $737.41

These projections assume Synopsys executes on Ansys synergies and scales IP monetization. Upside could come from faster agentic EDA pricing adoption, while downside could result from export control escalation or continued Design IP weakness.

Contact [email protected] for any questions or corrections.

Photo of Vandita Jadeja
About the Author Vandita Jadeja →

Vandita Jadeja is a financial copywriter who loves to read and write about stocks. She believes in buying and holding for long term gains. Her knowledge of words and numbers helps her write clear stock analysis. She has contributed to several publications, including the Joy Wallet, Benzinga, The Motley Fool and InvestorPlace.

Continue Reading

Top Gaining Stocks

MRNA Vol: 185,642,278
EL Vol: 13,590,317
MRK Vol: 29,363,182
COIN Vol: 16,396,832

Top Losing Stocks

CTRA Vol: 73,319,495
STX Vol: 5,740,482
STLD Vol: 2,401,880
WDC Vol: 6,707,365
DELL Vol: 6,323,753